Eyal Attar
Chief Tech/Sci/R&D Officer bij VOR BIOPHARMA INC.
Vermogen: 267 569 $ op 31-03-2024
Profiel
Eyal C.
Attar is currently the Chief Medical Officer at Vor Biopharma, Inc. Prior to this, he worked as the Senior Medical Director at Agios Pharmaceuticals, Inc. from 2016 to 2019.
He also served as the Chief Medical Officer & Senior Vice President at Aprea Therapeutics, Inc. Dr. Attar's education includes a doctorate degree from UNC School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VOR BIOPHARMA, INC.
0.17% | 06-02-2024 | 112 853 ( 0.17% ) | 267 462 $ | 31-03-2024 |
APREA THERAPEUTICS, INC.
0.00% | 26-06-2023 | 16 ( 0.00% ) | 107 $ | 31-03-2024 |
Actieve functies van Eyal Attar
| Bedrijven | Functie | Begin |
|---|---|---|
| VOR BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 12-10-2022 |
Eerdere bekende functies van Eyal Attar
| Bedrijven | Functie | Einde |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2019 |
| Harvard Medical School | Corporate Officer/Principal | - |
| APREA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Eyal Attar
| UNC School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
